NCT01986556View on ClinicalTrials.gov

Lesinurad Tablet Relative Bioavailability

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy
Interventions
DRUG

Lesinurad 400 mg (Site 1)

DRUG

Lesinurad 400 mg (Site 2, Lot A)

DRUG

Lesinurad 400 mg (Site 2, Lot B)

Trial Locations (1)

91206

Glendale

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY